We have used IHC to determine expression levels in breast tumours of the main regulatory molecules of the eIF4E pathway – namely, eIF4E, 4E-BP1, 4E-BP2 and phosphorylated 4E-BP1 (Thr37/46) (termed p4E-BP1). The gene discussed is EIF4EBP2; the disease is breast neoplasm.